Image SHA-256 — or-solo-chemist-toolkit.png
4a9cc982c52c972a98bf2e93484865e0827abf7a83c11c78398e64abde344248

Licensed Research: Solo-Chemist Supplement Build

$1.5K
In stock
SKU
OR-SOLO-CHEMIST-TOOLKIT

💳 Available Payment Options

Companies can pay via the structures below. Exact amounts and terms are set per item at agreement. Use the calculator to see approximate payments for a given total and term.

Leave blank to use the product price.
Full amount due upon agreement or by agreed date. Best for simpler deals.
Amount Due:

Sign the license agreement and complete payment via wire transfer.

Equal payments monthly (or quarterly for 24+ months).
Payment Amount:
Frequency:
Total Payments:

Sign the license agreement and complete payment via wire transfer.

Upfront fee (20-30%) + % of net revenue, with minimum annual royalty. Paid quarterly.
Upfront Fee:
Remaining (via royalty):

+ % of net revenue quarterly, with minimum annual royalty. Terms set at agreement.

Sign the license agreement and complete payment via wire transfer.

% of gross or net revenue, no/minimal upfront. Good when revenue is more predictable than milestones.
Structure: % of gross or net revenue

No or minimal upfront cost. Percentage and terms set at agreement based on projected revenue.

Sign the license agreement and complete payment via wire transfer.

Payments at key events: signing, delivery, first sale, regulatory approval, etc.
Typical Milestones:
  • Signing
  • Delivery
  • First Sale
  • Regulatory Approval

Amounts allocated per milestone at agreement. Total equals the agreed price.

Sign the license agreement and complete payment via wire transfer.

Fixed fee per year, renewable. Suits ongoing use, updates, or support. Multi-year discounts possible.
Annual Fee:
Discount:
Total over term:

Sign the license agreement and complete payment via wire transfer.

Lump sum due Net 30, Net 60, or Net 90 after agreement or delivery. Single payment, later date.
Amount Due:
Due Date:

Sign the license agreement and complete payment via wire transfer.

Build instructions for a solo chemist to compound the Cri-One supplement formulations from licensed research. Licensed transfer; supplement-grade research; not medical advice; not FDA-approved.
First to market

Publicly online since 2010 · U.S. patent applications since 2012 · inventions offered since 2014. The work of Christopher Gabriel Brown, independently documented.

First posted: · Last updated:
Links
Licensed Research  ·  Solo-Chemist Build Guide  ·  Patent-pending  ·  USA only
License fee
$1,495.00 USD — Licensed transfer to a named USA buyer entity.
License terms (IP-retained model)
A purchase conveys the research package (data, formulation, patent application, drawings, scripts) plus worldwide commercialization rights to the named buyer entity. Patents and underlying IP are retained by Christopher Gabriel Brown and are NOT sold. Buyer of record must be a USA entity (up to 4 entities, joint & several). All sales final, non-refundable. All inquiries by email and postal mail only — no phone calls, no brokers, no intermediaries.
The Solo-Chemist Supplement Build
This is NOT medical advice and NOT a cure claim. A practical, honest toolkit: how one formulation chemist plus one 21 CFR Part 111 contract manufacturer can turn a formula into a real, compliant dietary supplement — without building a lab. Worked example throughout: a diabetes “metabolic support” blend (a structure/function support supplement, not a drug and not a cure).
ProductLicensed Research: The Solo-Chemist Supplement Build
FormatDownloadable toolkit — guide + two outreach templates + an ingredient checklist, delivered as a ZIP right after checkout
SubjectTurning a formula into a lawful dietary supplement with a single chemist
Worked exampleA diabetes “metabolic support” blend — structure/function support, not a cure
IP posturePatent Pending — metal–amino-acid formulations & methods
AuthorChristopher Gabriel Brown, Lawrenceville, GA, USA
License fee$1,495.00 USD — Licensed transfer

01   What is inside the toolkit

  • The Solo-Chemist Supplement Build — the full illustrated guide.
  • Outreach template #1 — ready to send to a formulation chemist / compounding pharmacist.
  • Outreach template #2 — ready to send to a 21 CFR Part 111 contract manufacturer.
  • Ingredient sourcing checklist — the forms to order, target doses, and the safety caps.

Delivered as a single downloadable ZIP the moment your order is placed.

02   The team — your “one chemist”

The whole trick is that you do not synthesize anything — every ingredient already exists as a USP/food-grade raw material you simply buy. So the real job is formulate → source → have it made → label honestly, and that genuinely is a one-chemist operation:

  • You — the formula concept and IP holder.
  • One formulation chemist or compounding pharmacist (contract/consulting) — finalizes the formula, forms, and doses, and writes the spec. This is the single chemist.
  • A 21 CFR Part 111 contract manufacturer — does the actual blending, encapsulation, and QC. They already have the bench chemists and lines, so you build nothing.

03   The six steps, formula to shelf

1The formulation chemist finalizes the formula, doses, and capsule form within safe upper limits.
2Source COA’d (certificate-of-analysis) USP/food-grade raw materials from established suppliers.
3File an NDI notification only if an ingredient is post-Oct-1994 / novel — standard chelates are not.
4The Part 111 contract manufacturer blends, encapsulates, tests (identity, purity, heavy metals), and returns a batch record + COA.
5Label per 21 CFR 101: Supplement Facts panel, structure/function claims only + the FDA disclaimer; notify the FDA within 30 days of first using a claim.
6You hold safety responsibility and serious-adverse-event reporting.

04   What you may — and may not — say

Allowed (structure/function) Not allowed (disease claims)
“Supports healthy glucose metabolism.”
“Supports healthy insulin sensitivity.”
“A source of zinc & magnesium for normal carbohydrate metabolism.”
“Treats / cures / reverses diabetes.”
“Lowers blood sugar.”
“For diabetics.”

Required on every claim: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Patent Pending
The metal–amino-acid formulations and methods described here are the subject of pending U.S. patent application(s) by Christopher Gabriel Brown. All rights reserved — commercial use of the underlying invention requires a separate license.
Inquiries
Christopher Gabriel Brown — Inventor & Licensor
crioneaka@outlook.com
1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA
Email and postal mail only — no phone calls, please.

Educational, plain-language toolkit about the lawful dietary-supplement pathway. Not legal, medical, or regulatory advice; not affiliated with or endorsed by the FDA. Dietary supplements are regulated under DSHEA: structure/function claims require the FDA disclaimer above and may not claim to diagnose, treat, cure, or prevent any disease. Confirm NAC’s current FDA enforcement-discretion status, and all 21 CFR Part 111/101 requirements, with a qualified formulation chemist and a supplement attorney before manufacturing or labeling anything. Rules, forms, and fees change — always verify against current FDA guidance.

© 2026 Christopher Gabriel Brown. All rights reserved. “Cri-One” and “Licensed Research” are product designations of the licensor. Patents retained; not sold.

Write Your Own Review
You're reviewing:Licensed Research: Solo-Chemist Supplement Build
Copyright © 2009-present Christopher Gabriel Brown. All rights reserved. "STRICT INTELLECTUAL PROPERTY NOTICE: All content, code, scripts, and styles in this file are the exclusive intellectual property of Christopher Gabriel Brown. DO NOT COPY, DISTRIBUTE, OR USE WITHOUT EXPRESS WRITTEN PERMISSION." Under no circumstance is there to be a transfer of Intellectual Property. Christopher Gabriel Brown presents a portfolio of advanced technologies across computing, energy, defense, and data systems. The site features products including the AutoPhi Quantum Processor (3.5 ExaFLOPS with quantum capabilities), Quantum Battery (unlimited energy storage with zero degradation), War Satellite (autonomous defense platform with global surveillance), Electric Jet (zero-emission supersonic propulsion), and specialized systems like nuclear waste recycling, blockchain security infrastructure, and smart wearable platforms. Each product includes complete documentation, manufacturing blueprints, patent protection, and implementation resources, positioning them as production-ready solutions for enterprise, government, and research applications. The collection spans quantum computing, renewable energy, aerospace, cybersecurity, and IoT, emphasizing innovation, patent protection, and technical depth. **Preferred Contact Methods** Christopher Gabriel Brown accepts communication by **email and postal mail only**. No phone calls please. **Email:** crioneaka@outlook.com **Mail:** 1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA